Wednesday, August 29, 2012

New breast cancer drug proves effective for a longer life (Video)

An article in the Boston Business Journal by Julie M. Donnelly, Reporter, stated that ImmunoGen Inc. and drug maker Roche AG are awaiting approval by the Food and Drug Administration for their breast cancer treatment that increases the survival rate for women with HER2-positive cancer.

Both companies spoke about their Phase 3 trial with the new drug called T-DM1. The trial revealed that patients on the drug experienced greater numbers of survivors than patients taking current drug treatments.

If approved by the FDA, this would be ImmunoGen’s first cancer-killing product. ImmunoGen is a biotechnology company that develops anticancer products using Targeted Antibody Payload (TAP) technology and antibody expertise, according to a press release on Aug. 27, 2012. The new drug is in global development by Roche under an agreement between ImmunoGen and Genentech, a member of the Roche Group.

This is great news for patients whose cancer has spread and conventional treatments have taken them as far as they can go. The news should stand as a reminder for all people, male and female, to regularly check the breasts for suspicious lumps and any pain or swelling. The key to curing cancer is catching it in its earliest stages, before the cancer has time to spread throughout the body.

The herb turmeric from India, the dried root of the curcumin plant, has proven effective at preventing cancerous tumors. The root, or rhizome, of the plant contains the active ingredient curcumin. It has been used for hundreds of years in India and other Asian countries as a spice. It can be purchased in most grocery stores as a spice or in supplement form. Used daily, the odds of a cancer diagnosis drop dramatically.

Cancer drugs are necessarily rough on the body. The treatments can be as painful as the disease. For natural health, preventative measures should be used, including losing weight, which is said to be a factor in breast cancer.

According to the National Cancer Institute, “Obesity is associated with increased risks of cancers of the esophagus, breast (postmenopausal), endometrium (the lining of the uterus), colon and rectum, kidney, pancreas, thyroid, gallbladder, and possibly other cancer types.



No comments:

Post a Comment